Khattab, Elina and Christaki, Eirini and Pitsios, Constantinos (2022) Pityriasis Rosea Induced by COVID-19 Vaccination. European Journal of Case Reports in Internal Medicine, 9 (2). pp. 1-3. ISSN 2284-2594
|
Text
3164-Article Text-27209-1-10-20220201.pdf - Published Version Download (416kB) | Preview |
Abstract
It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect. We present two cases of COVID-19 vaccine-induced pityriasis rosea. Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same vaccine. The exanthem was self-limited in both patients over a period of a month.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | COVID-19, SARS-CoV-2, vaccination, pityriasis rosea |
Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) |
Depositing User: | Marina Spanti |
Date Deposited: | 14 Apr 2022 12:40 |
Last Modified: | 14 Apr 2022 12:40 |
URI: | http://eprints.bice.rm.cnr.it/id/eprint/21806 |
Actions (login required)
View Item |